Author Page for Westain Nyirenda

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Fexinidazole as a New Oral Treatment for Human African Trypanosomiasis Due to Trypanosoma Brucei Rhodesiense: A Prospective, Open-Label, Single-Arm, Phase 2-3, Benchmark Study

Number of pages: 26 Posted: 08 Oct 2024

Enock Matovu, Westain Nyirenda, Anthony Eriatu, Deolinda Alves, Christelle Perdrieu, Marshal Lemerani, Charles Wamboga, Veerle Lejon, Jorge Seixas, Aita Signorell, Anne Reymondier, Elisabeth Baudin, Bruno Scherrer and Olaf Valverde Mordt

Makerere University, Rumphi District Hospital, Lwala Hospital, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Ministry of Health (Malawi), Republic of Uganda Ministry of Health, Institut de Recherche pour le Développement, University of Lisbon, University of Basel - Swiss Tropical and Public Health Institute, Drugs for Neglected Diseases Initiative (DNDi), Epicentre (Paris), Bruno Scherrer Conseil and Drugs for Neglected Diseases Initiative (DNDi)

Downloads 90 (742,061)

Westain Nyirenda

Rumphi District Hospital

1

90

0

Scholarly Papers (1)

Fexinidazole as a New Oral Treatment for Human African Trypanosomiasis Due to Trypanosoma Brucei Rhodesiense: A Prospective, Open-Label, Single-Arm, Phase 2-3, Benchmark Study

Abstract: